Coenzyme Q10 100 mg

Coenzyme Q10 100 mg

Natural Factors4.7 (14,071 ratings)
Format:Softgel Quantity: 120 Softgel(s) · 120 servings
Goals
$27.97 $0.23 per serving

Product analysis

76 out of 100

Coenzyme Q10 100 mg offers an economical CoQ10 supplement with limited support for blood-vessel function and related heart-health measurements in selected groups.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality40

The CoQ10 form is identified, but a quality or absorption advantage is not established. Ubiquinone should not be assumed equivalent to a special delivery system.

Ingredient Transparency100

The CoQ10 amount and form are clearly identified. That makes the serving straightforward to compare with other ubiquinone supplements.

Value For Money100

The CoQ10 serving offers favorable value. It is an economical option when comparing a similar amount of the same form.

Customer Satisfaction91

Customer ratings are very positive across a large number of reviews. The broad review base supports confidence in satisfaction without proving health effects.

Product Focus70

CoQ10 has limited support for heart-related measurements in selected groups. Its role in cellular energy does not establish a routine energy boost, faster calorie burning or longer life.

Format
Softgel
Container
120 Softgel(s)
Per serving
$0.23
Customer rating
4.7 · 14,071 ratings
Report analysis

Goals

Energy
Impact
High effect
B- Ingredient FitF PathwaysB+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 participates in cellular energy processes, but the relevant fatigue evidence is limited and preparation-specific. The declared preparation receives partial amount recognition in the saved comparison. Neither its biochemical role nor results from clinical disease groups establish a routine energy boost in healthy adults, and ubiquinol is not assigned an absorption advantage.

How this product is rated for Energy

Ingredient fit73

Coenzyme Q10 receives recognition in the saved ingredient and amount findings, with its practical role limited by the supplied context.
Goal fit
The recognized nutrient is the formula’s main focus; other linked uses do not establish additional energy benefits.
Dose adequacy
The amount provides partial coverage of the saved comparison, without establishing a fatigue-treatment dose.

Pathways17

The strongest saved connection concerns mitochondrial energy production, subject to the preparation and population limits described above.
Depth
The strongest saved connection concerns mitochondrial energy production, subject to the preparation and population limits described above.
Breadth
No configured energy area reaches the saved coverage threshold. Nutritional relevance and pathway coverage are separate findings.

Evidence84

Coenzyme Q10 leads the saved evidence finding, with limited preparation-specific fatigue support.
Evidence strength
Coenzyme Q10 leads the saved evidence finding, with limited preparation-specific fatigue support.
Studied preparation
The saved finding accepts the preparation; it does not establish superiority of a particular form or remove the relevant evidence limitations.

Formulation logic100

The recognized ingredients meet the saved partner and amount checks, and no configured conflict was identified.
Partner coverage
The recognized ingredients meet the saved partner checks; no added effect from combining them is established.
Conflicts
No configured ingredient conflict was identified from the available facts.
Effective doses
The recognized ingredients reach the saved amount threshold, which is a comparison point rather than proof of a fatigue-treatment dose.
Study evidence
Cardiovascular Support
Impact
Highest effect
A- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 offers limited support for blood-pressure, lipid and blood-vessel lining markers in people with dyslipidemia. This serving provides 100 mg as ubiquinone, a partial comparison with the supplied 120 mg daily study exposure. Those marker findings do not establish cardiovascular-event prevention or a special advantage for this form.

How this product is rated for Cardiovascular Support

Ingredient fit86

The declared ingredients are concentrated on the cardiovascular roles considered here. The declared Coenzyme Q-10 amount supports the saved exposure comparison; it does not predict the size of a benefit.
Goal fit
The declared ingredients are concentrated on the cardiovascular roles considered here.
Dose adequacy
The declared Coenzyme Q-10 amount supports the saved exposure comparison; it does not predict the size of a benefit.

Pathways53

Blood-vessel lining function is the strongest represented area, based on limited CoQ10 marker findings.
Depth
Blood-vessel lining function is the strongest represented area, based on limited CoQ10 marker findings.
Breadth
One cardiovascular area meets the saved coverage threshold, so the support is concentrated rather than broad.

Evidence88

CoQ10 has limited blood-pressure, lipid and endothelial-marker findings in dyslipidemia.
Evidence strength
CoQ10 has limited blood-pressure, lipid and endothelial-marker findings in dyslipidemia.
Studied preparation
The saved preparation comparison accepts the qualifying ingredients, but that finding does not extend the evidence beyond the populations and outcomes described.

Formulation logic100

The qualifying ingredients have no missing required partners or matched conflicts in the supplied checks.
Partner coverage
No required partner is missing for the credited ingredients; this does not establish an extra benefit from combining them.
Conflicts
No matching formulation conflict was identified in the supplied checks.
Effective doses
All qualifying ingredients meet the saved minimum amount threshold, which is an exposure comparison rather than proof of effectiveness.
Study evidence
Longevity
Impact
Moderate effect
B- Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

CoQ10 at 100 mg supports normal cellular energy production and antioxidant activity. The supplied visible-skin-aging evidence applies to a specific water-soluble preparation, so it offers limited support for expecting the same effects from this form or for extending lifespan.

How this product is rated for Longevity

Ingredient fit73

The counted ingredients are closely focused on the goal's saved findings. The counted amounts provide partial support against the saved targets.
Goal fit
The counted ingredients are closely focused on the goal's saved findings.
Dose adequacy
The counted amounts provide partial support against the saved targets.

Pathways10

The strongest saved coverage concerns cellular energy production.
Depth
The strongest saved coverage concerns cellular energy production.
Breadth
No area reaches the saved threshold for broad coverage.

Evidence30

CoQ10 provides the strongest evidence contribution in the saved findings, which should be understood as support for a limited outcome rather than extended lifespan. CoQ10 does not match the preparation used for the cited skin-aging evidence.
Evidence strength
CoQ10 provides the strongest evidence contribution in the saved findings, which should be understood as support for a limited outcome rather than extended lifespan.
Studied preparation
CoQ10 does not match the preparation used for the cited skin-aging evidence.

Formulation logic100

The counted ingredients meet the saved minimum amounts and have no listed conflict.
Partner coverage
The counted ingredients can contribute independently or have the required partner.
Conflicts
The saved check identified no listed ingredient conflict; this is not a general safety assessment.
Effective doses
1 of 1 counted ingredients meet the saved minimum amount threshold.
Study evidence
Heart Health
Impact
Highest effect
A- Ingredient FitD+ PathwaysA+ EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10, declared as ubiquinone, has limited support from small studies of vascular, blood-pressure and lipid measurements. Its 100 mg serving largely meets the preparation's saved comparison, with the main contribution assigned to endothelial function. These selected-population findings do not establish routine cardiovascular-event prevention. The preparation identity does not show an absorption advantage over other CoQ10 forms or make it equivalent to a branded delivery system.

How this product is rated for Heart Health

Ingredient fit86

Declared conventional CoQ10 provides a focused preparation-specific contribution and largely meets its comparison.
Goal fit
CoQ10 is the sole credited ingredient and relates to limited vascular evidence.
Dose adequacy
The 100 mg serving largely meets its preparation-specific exposure comparison.

Pathways53

Endothelial nitric-oxide function is the strongest assigned area. Only endothelial function reaches substantial coverage.
Depth
Endothelial nitric-oxide function has the strongest saved coverage; that assignment does not establish prevention of cardiovascular events.
Breadth
Only endothelial function reaches substantial coverage.

Evidence98

CoQ10 leads the saved support finding, limited to small selected-population vascular and blood-pressure results.
Evidence strength
Coenzyme Q10 leads the saved evidence finding, within the preparation, population and outcome limits of the supplied context.
Studied preparation
Credited preparations meet the saved criteria; this does not extend selected-population or surrogate findings to general event prevention.

Formulation logic100

Credited ingredients clear the saved amount threshold and have no assessed missing partner or conflict.
Partner coverage
Credited ingredients work alone or have their relevant partners; no additional combination benefit follows from this finding.
Conflicts
No assessed ingredient conflict was triggered.
Effective doses
All credited ingredients clear the saved minimum amount threshold, which is not proof of cardiovascular benefit.
Study evidence
Metabolism Support
Impact
High effect
B- Ingredient FitF PathwaysB- EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 helps mitochondria transfer energy within cells. That role and studies of metabolic markers do not establish that supplementation increases whole-body energy expenditure in adults with adequate levels. The supplied evidence does not support a routine metabolism boost or a lasting fat-loss benefit from this serving.

How this product is rated for Metabolism Support

Ingredient fit73

Coenzyme Q10 relates to cellular energy handling, with partial coverage of the supplied amount comparison.
Goal fit
Coenzyme Q10 is the sole recognized active relevant to cellular energy, though that does not demonstrate increased calorie expenditure.
Dose adequacy
The 100 mg serving provides partial coverage of the supplied amount comparison; this is not a proven thermogenic dose.

Pathways17

Mitochondrial energy handling is the principal connection, without establishing increased whole-body calorie use.
Depth
The saved finding centers on mitochondrial energy handling, which does not itself show an increase in whole-body energy expenditure.
Breadth
No evaluated pathway reaches the supplied coverage threshold.

Evidence75

Coenzyme Q10’s cellular role and metabolic-marker evidence support the saved finding, while evidence of routine increased energy expenditure remains lacking.
Evidence strength
Coenzyme Q10 supplies the evidence finding, but its cellular energy role and metabolic-marker studies do not demonstrate routine thermogenesis.
Studied preparation
The counted preparations match those recognized in the supplied comparison; this does not establish thermogenic benefit for the finished product.

Formulation logic100

No unmet partner requirement or specified conflict was identified. The counted ingredients meet the supplied minimum amount comparisons.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings; this does not establish additional benefit from combining them.
Conflicts
No specified ingredient conflict was identified in the supplied findings.
Effective doses
All counted ingredients meet the supplied minimum amount comparison, which is not a demonstrated threshold for increased calorie expenditure.
Study evidence
Inflammation
Impact
High effect
C+ Ingredient FitF PathwaysA EvidenceA+ Formulation Logic
Coenzyme Q-10 · 100 mg

Coenzyme Q10 has limited inflammation-marker evidence from a small ubiquinone trial in statin-treated people with coronary disease. TNF-alpha differed from placebo, while CRP and IL-6 did not. The 100 mg serving is below the 300 mg daily study exposure. These context-specific findings do not establish routine clinical anti-inflammatory benefit.

How this product is rated for Inflammation

Ingredient fit66

Coenzyme Q-10 provides the main ingredient connection. Its saved amount comparison is distinct from a proven clinical anti-inflammatory dose.
Goal fit
Coenzyme Q-10 provides the main ingredient connection, while the product is also linked to other goals.
Dose adequacy
The included amount only partly matches the saved comparison exposure, limiting the amount finding without quantifying expected clinical benefit.

Pathways13

The strongest connection is oxidative and mitochondrial stress. Other reviewed mechanisms have limited coverage.
Depth
The main supplied connection is oxidative and mitochondrial stress, through Coenzyme Q-10. This mechanism does not establish relief of inflammatory symptoms.
Breadth
No reviewed mechanism reaches the saved coverage threshold, leaving limited support across the goal.

Evidence93

Coenzyme Q-10 leads the saved evidence finding. Human findings remain narrow and do not establish routine broad clinical benefit.
Evidence strength
Coenzyme Q-10 leads the saved evidence comparison; the supplied human outcomes remain limited by the specific biomarker, population and preparation findings.
Studied preparation
The included ingredients match preparations recognized in the saved comparison; clinical applicability still depends on the populations and outcomes studied.

Formulation logic100

No missing required partner or matched conflict was identified, and the included ingredients meet the saved amount threshold.
Partner coverage
The relevant ingredients act independently or have their required partner; this does not establish an extra benefit from combining them.
Conflicts
No conflict was identified by the supplied checks; this is a limited formulation finding rather than a general safety conclusion.
Effective doses
The included ingredients meet the saved amount threshold, which is not a proven minimum dose for clinical anti-inflammatory benefit.
Study evidence

Ingredients

IngredientAmount per servingScore
Coenzyme Q10 (Ubiquinone)
100 mg 72
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
D Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
Each serving supplies 100 mg of CoQ10 as ubiquinone. The named form makes it easier to compare with products using other forms of CoQ10.
How this ingredient is rated

Active Ingredient Quality & Bioavailability48

The CoQ10 is identified as ubiquinone, the oxidized form.
Molecular Form: Ubiquinol vs. Ubiquinone
The available facts identify the CoQ10 as ubiquinone.
Formulation & Absorption Enhancers
The available facts do not identify a liposomal, micellar or nano-emulsion claim, or an added black pepper extract.

Dose, Safety & Label Transparency83

The label states 100 mg of CoQ10 per serving. No listed problem additives or standard fillers were flagged.
Clinical Dosage Alignment
Each serving provides 100 mg of CoQ10.
Label Transparency & Fillers
The label states 100 mg per serving; the evaluation did not flag the listed problem additives or standard fillers.

Value100

The whole-product price works out to about $0.23 per 100 mg of CoQ10.
Price Per Effective Serving
The whole-product price works out to about $0.23 per 100 mg of CoQ10.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.
    Liu Z; Tian Z; Zhao D; Liang Y; Dai S; Liu M; Hou S; Dong X; Zhaxinima; Yang Y · The Journal of clinical endocrinology and metabolism · 2022
    Meta-analysis2,794 participants50 studies pooledCardiovascular Support Heart Health forCoenzyme Q-10
  2. Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.
    Vrentzos E; Ikonomidis I; Pavlidis G; Katogiannis K; Korakas E; Kountouri A; Pliouta L; Michalopoulou E; Pelekanou E; Boumpas D; Lambadiari V · Cardiovascular diabetology · 2024
    Randomized trial60 participantsCardiovascular Support forCoenzyme Q-10
  3. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.
    Mortensen SA; Rosenfeldt F; Kumar A; Dolliner P; Filipiak KJ; Pella D; Alehagen U; Steurer G; Littarru GP; Q-SYMBIO Study Investigators · JACC. Heart failure · 2015
    Randomized trial420 participantsCardiovascular Support forCoenzyme Q-10
  4. [Coenzyme Q-10 in the treatment of patients with chronic heart failure and reduced left ventricular ejection fraction: systematic review and meta-analysis].
    Mareev VY; Mareev YV; Begrambekova YL · Kardiologiia · 2022
    Meta-analysis1,139 participants6 studies pooledCardiovascular Support forCoenzyme Q-10
  5. Effect of coenzyme Q10 in Europeans with chronic heart failure: A sub-group analysis of the Q-SYMBIO randomized double-blind trial.
    Mortensen AL; Rosenfeldt F; Filipiak KJ · Cardiology journal · 2020
    Randomized trialCardiovascular Support forCoenzyme Q-10
  6. Effects of Coenzyme Q10 on Statin-Induced Myopathy: An Updated Meta-Analysis of Randomized Controlled Trials.
    Qu H; Guo M; Chai H; Wang WT; Gao ZY; Shi DZ · Journal of the American Heart Association · 2019
    Meta-analysis575 participants12 studies pooledEnergy forCoenzyme Q-10
  7. Coenzyme Q10 Supplementation in Athletes: A Systematic Review.
    Fernandes MSS; Fidelis DEDS; Aidar FJ; Badicu G; Greco G; Cataldi S; Santos GCJ; de Souza RF; Ardigò LP · Nutrients · 2026
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  8. Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsai IC; Hsu CW; Chang CH; Tseng PT; Chang KV · Frontiers in pharmacology · 2024
    Meta-analysis1,126 participants13 studies pooledEnergy forCoenzyme Q-10
  9. Antifatigue effects of coenzyme Q10 during physical fatigue.
    Mizuno K; Tanaka M; Nozaki S; Mizuma H; Ataka S; Tahara T; Sugino T; Shirai T; Kajimoto Y; Kuratsune H; Kajimoto O; Watanabe Y · Nutrition (Burbank, Los Angeles County, Calif.) · 2008
    Randomized trial17 participantsEnergy forCoenzyme Q-10
  10. Effect of coenzyme Q10 supplementation on fatigue: A systematic review of interventional studies.
    Mehrabani S; Askari G; Miraghajani M; Tavakoly R; Arab A · Complementary therapies in medicine · 2019
    Systematic review16 studies pooledEnergy forCoenzyme Q-10
  11. Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.
    Sabbatinelli J; Orlando P; Galeazzi R; Silvestri S; Cirilli I; Marcheggiani F; Dludla PV; Giuliani A; Bonfigli AR; Mazzanti L; Olivieri F; Antonicelli R; Tiano L · Nutrients · 2021
    Randomized trial51 participantsHeart Health forCoenzyme Q-10
  12. Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A Grading of Recommendations Assessment, Development, and Evaluation (GRADE)-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Zhao D; Liang Y; Dai S; Hou S; Liu Z; Liu M; Dong X; Zhan Y; Tian Z; Yang Y · Advances in nutrition (Bethesda, Md.) · 2022
    Meta-analysis1,831 participants26 studies pooledHeart Health forCoenzyme Q-10
  13. Effects of Coenzyme Q10 on Lipid, Glycemic, and Inflammatory Markers in Metabolic Disorders: A Systematic Review and Meta-Analysis.
    Zhang Z; Liu Z; Geng Y; Huang Y; Hu R; Li F; Song Y; Zhang M · Journal of diabetes research · 2026
    Meta-analysis3,422 participants64 studies pooledHeart Health Metabolism Support forCoenzyme Q-10
  14. Treatment of coenzyme Q10 for 24 weeks improves lipid and glycemic profile in dyslipidemic individuals.
    Zhang P; Yang C; Guo H; Wang J; Lin S; Li H; Yang Y; Ling W · Journal of clinical lipidology · 2019
    Randomized trial101 participantsHeart Health forCoenzyme Q-10
  15. The effect of coenzyme Q10 supplementation on inflammatory and endothelial dysfunction markers in overweight/obese polycystic ovary syndrome patients.
    Taghizadeh S; Izadi A; Shirazi S; Parizad M; Pourghassem Gargari B · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2021
    Randomized trial43 participantsInflammation forCoenzyme Q-10
  16. The effects of coenzyme Q10 supplementation on metabolic profiles and parameters of mental health in women with polycystic ovary syndrome.
    Karamali M; Gholizadeh M · Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology · 2022
    Randomized trial55 participantsInflammation forCoenzyme Q-10
  17. Efficacy and Optimal Dose of Coenzyme Q10 Supplementation on Inflammation-Related Biomarkers: A GRADE-Assessed Systematic Review and Updated Meta-Analysis of Randomized Controlled Trials.
    Hou S; Tian Z; Zhao D; Liang Y; Dai S; Ji Q; Fan Z; Liu Z; Liu M; Yang Y · Molecular nutrition & food research · 2023
    Meta-analysis1,517 participants31 studies pooledInflammation forCoenzyme Q-10
  18. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
    Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M · Pharmacological research · 2020
    Meta-analysis509 participants9 studies pooledInflammation forCoenzyme Q-10
  19. Promising efficacy of coenzyme Q10 supplementation as adjunctive therapy in juvenile idiopathic arthritis: a randomized-controlled pilot study.
    Elsherif N; Shousha G; Sabri NA; Shawki MA · Immunopharmacology and immunotoxicology · 2026
    Randomized trial58 participantsInflammation forCoenzyme Q-10
  20. Coenzyme Q10 and Degenerative Disorders Affecting Longevity: An Overview.
    Mantle D; Hargreaves I · Antioxidants (Basel, Switzerland) · 2020
    Narrative reviewLongevity forCoenzyme Q-10